Raykov Rosty 4
4 · FENNEC PHARMACEUTICALS INC. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Fennec (FENC) Director Raykov Rosty Exercises Options, Sells Shares
What Happened
- Director Raykov Rosty exercised stock options and completed a related share sale. On 2026-05-01 he exercised 15,598 options at $2.45 per share (cost = $38,215). That same day he sold 10,781 shares in the open market at $6.47 per share, receiving $69,753. Additionally, 2,778 restricted shares awarded 5/16/2024 were released to him on 2026-04-30 (no cash paid).
Key Details
- Transaction dates and prices:
- 2026-04-30: 2,778 shares released from restriction (F1) — acquired at $0.00.
- 2026-05-01: Exercised 15,598 options at $2.45/share (Acquired) — $38,215 (F2, F4).
- 2026-05-01: Sold 10,781 shares in open market at $6.47/share — $69,753 (F3).
- Filing accession: 0001468316-26-000013; report filed 2026-05-01 (timely).
- Shares owned after the transactions: not specified in the provided transaction details.
- Notable footnotes:
- F1: release of restricted shares awarded 5/16/2024.
- F2/F4: exercise occurred pursuant to a 10b5-1 plan adopted 9/19/2025.
- F3: the open-market sale was to satisfy tax obligations from the option exercise (per the 10b5-1 plan).
- Timeliness: Report covers transactions on 4/30 and 5/01 and was filed on 2026-05-01 — appears timely.
Context
- This was an option exercise with immediate share disposition to cover taxes (a common, routine cashless outcome) rather than a standalone buy indicating new bullish conviction. M = option exercise/conversion; S = sale. The exercise required outlay ($2.45/share); some shares were sold under the 10b5-1 plan to satisfy tax withholding.
Insider Transaction Report
Form 4
Raykov Rosty
Other
Transactions
- Exercise/Conversion
Common shares
[F1]2026-04-30+2,778→ 116,634 total - Exercise/Conversion
Common shares
[F2]2026-05-01$2.45/sh+15,598$38,215→ 132,232 total - Sale
Common shares
[F3]2026-05-01$6.47/sh−10,781$69,753→ 121,451 total - Exercise/Conversion
Stock Options
[F4]2026-05-01$2.45/sh−15,598$38,215→ 1,571,792 totalExercise: $2.45From: 2016-07-05Exp: 2026-07-05→ options (15,598 underlying)
Footnotes (4)
- [F1]Represents shares released from restriction from shares awarded 5/16/2024.
- [F2]Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.
- [F3]Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025.
- [F4]Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.
Signature
/s/ Rosty Raykov|2026-05-01